Clinical Trial Update: SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating SB-497115 versus placebo in adults with cancer receiving chemotherapy has completed. The study targets chemotherapy-induced thrombocy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• SB-497115

Snippet

Sponsor: GlaxoSmithKline | Conditions: Thrombocytopaenia | Phase 2 | Status: COMPLETED